Data from the 003-A1 study were previously presented at the 52nd American Society of Hematology Annual Meeting in December 2010 and at subsequent international scientific meetings. The trial was conducted in collaboration with the Multiple Myeloma Research Consortium (MMRC) and at additional sites in the United States and Canada.Important Safety Information Regarding Kyprolis™ (carfilzomib) for Injection
Onyx Pharmaceuticals Announces Kyprolis™ Study Published In The Medical Journal Blood
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.